Home Healthcare Pharmaceuticals Europe Aesthetic Medicine Market

Europe Aesthetic Medicine Market Size, Share & Trends Analysis Report By Procedure Type (Invasive Procedures, Non-invasive Procedures), By End Use (Hospitals, Clinics & Aesthetic Centers, Medspas) and By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2026-2034

Last Updated: September 24, 2026 | Author: Debashree Bora | Format:

Europe Aesthetic Medicine Market Size

The global aesthetic medicine market size was valued at USD 21.55 billion in 2025 and is projected to reach USD 23.77 billion in 2026 to USD 51.99 billion by 2034, growing at a CAGR of 10.28% during the forecast period (2026-2034). With an expected valuation of USD 124.34 billion, Europe is the third-largest market for aesthetic medicines. For the period of 2026 to 2034, the CAGR of Aesthetic Medicines is expected to be 14.71% for the European market.

Aesthetic treatments, often known as cosmetic treatments, are non-surgical procedures that are intended to reduce the appearance of wrinkles, renew the skin, and make it look younger. Fine line and wrinkle reduction, fat reduction, stretch mark cures, scar therapy, skin oxygenation and resurrection, body contouring and firming, botulinum toxin, and skin repair are all covered under medical aesthetics. Aesthetic medicine is primarily concerned with modifying a person's visual look to their liking. Scars, excess fat, skin discoloration, skin laxity, moles, and wrinkles are all treated with this procedure.

A variety of invasive, minimally invasive, and non-invasive cosmetic procedures are used in aesthetic medicine. The global medical aesthetics market is growing as the aged population becomes more aware of such treatments and accepts novel treatments. Furthermore, evolving consumer attitudes around wellness, beauty, and healthy aging have increased aesthetic awareness and acceptability, boosting demand from new patient categories like men and millennials.

Europe Aesthetic Medicine Market Size

Download a Free Sample To learn more about this report.

Europe Aesthetic Medicine Market Segmentation Analysis

By Procedure Type

Invasive Procedures include treatments that involve surgical or injectable techniques and are used for more significant aesthetic corrections and enhancements. Non-invasive Procedures use techniques that do not require surgical incisions and are used for treatments focused on skin quality, body contouring, rejuvenation, and other aesthetic concerns.

Europe Aesthetic Medicine Market Size By Segments

Request Customizationto receive a tailored report.

By End Use

Hospitals provide aesthetic procedures alongside broader medical services and can support treatments that require advanced clinical infrastructure. Clinics & Aesthetic Centers provide specialized aesthetic treatments and offer a dedicated setting for cosmetic procedures and patient consultations. Medspas combine aesthetic treatments with wellness-oriented services and provide convenient settings for minimally invasive and non-invasive procedures.

 

Europe Aesthetic Medicine Market Share By Segments

Speak to an Analystto discuss market opportunities.

Europe Aesthetic Medicine Market Regional Outlook

The Europe Aesthetic Medicine Market accounted for the largest regional share of 21.6% in 2025. The region maintained a strong market position due to increasing demand for aesthetic treatments and the availability of advanced cosmetic procedures.

The UK population is projected to reach 71.0 million by mid-2034, while the number of people aged 85 and over is expected to double from 1.75 million in 2024 to 3.6 million by 2049, expanding the potential older consumer base for aesthetic treatments.Germany is projected to have one in four people aged 67 or over by 2035, with the number of people in this age group expected to reach at least 20.5 million by the end of the 2030s, potentially supporting demand for age-related aesthetic procedures. INSEE projects the share of France’s population aged 75 and over to increase from 12.3% in 2030 to 14.8% in 2040, indicating a continued expansion of the older population segment relevant to age-related aesthetic treatments

 

Europe Aesthetic Medicine Market Competitive Landscape 

The Europe Aesthetic Medicine Market is highly fragmented, with the market ecosystem comprising pharmaceutical and medical technology companies, aesthetic device manufacturers, dermatology clinics, cosmetic surgery providers, medical spas, specialized aesthetic treatment centers, distributors, and regional service providers, reflecting a diverse market share.

Established players compete mainly through treatment efficacy, product safety, clinical evidence, technological innovation, practitioner training, brand reputation, regulatory compliance, broad product portfolios, and distribution networks, while the market ecosystem includes emerging and regional players that compete through specialized treatments, affordable pricing, customized treatment plans, minimally invasive solutions, localized services, digital patient engagement, and personalized care.

List of Key and Emerging Players in Europe Aesthetic Medicine Market

Evolus Inc.
AIVITA Biomedical
Ellman International, Inc.
Genesis Biosystems, Inc.
Lumenis Ltd.
Sciton, Inc.
Wells Johnson Company
Zeltiq Aesthetics, Inc.

Key Industry Developments

March 2026 – Merz Aesthetics introduced new digital education and treatment optimization programs across Europe to support physicians using its botulinum toxin and dermal filler portfolio, enhancing patient outcomes and clinical adoption.
September 2025 – Croma-Pharma expanded its facial aesthetics portfolio across Europe with new minimally invasive rejuvenation solutions, reinforcing its position in the region's growing aesthetic medicine market.
May 2025 – Sinclair strengthened its European aesthetic medicine business by expanding the commercialization of advanced collagen-stimulating injectable treatments to address increasing demand for non-surgical facial rejuvenation.
February 2025 – AbbVie expanded the European reach of its Allergan Aesthetics portfolio through new physician training initiatives and broader access to facial injectables and body contouring technologies.

Report Scope

Segmentation

By Procedure Type 2
  • Invasive Procedures
  • Non-invasive Procedures
By End Use 3
  • Hospitals
  • Clinics & Aesthetic Centers
  • Medspas
Competitive Coverage Evolus Inc. · AIVITA Biomedical · Ellman International, Inc. · Genesis Biosystems, Inc. · Lumenis Ltd.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The Europe aesthetic medicine market share growing at a CAGR of 10.28% from (2026–2034).

Increasing obesity, growing attention to diabetes care are the major growth factors of the Europe aesthetic medicine market.

Evolus Inc., AIVITA Biomedical, Ellman International, Inc., Genesis Biosystems, Inc. , Lumenis Ltd. , Sciton, Inc. , Wells Johnson Company are the prominent players in the Europe aesthetic medicine market.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: